In this Podcast, the LMB’s Greg Jefferis talks to Kerri Smith from Nature about a new algorithm that sorts neurons in the fly brain by type – and finds a few surprises. This article is no longer available from the source website
NeuroPod – Fly brain tidy-up
Discovery Could Help Turn Antibiotic Into Antimalarial Drug
Scientists in Melbourne and collaborators led by the LMB’s Sjors Scheres have made progress toward new antimalarial drugs, after revealing how an antibiotic called emetine blocks the molecular machinery that produces the proteins required for malaria parasite survival. More…
LMB wins Safe, Successful and Sustainable S-Lab Award 2014
The new LMB building has been announced as joint winner of the 2014 S-Lab award for new research laboratories worldwide. The award was presented at a gala ceremony in London on September 1st, and was accepted by the LMB Director Hugh Pelham and Steve Holmes who was involved in the construction project. The S-Lab Awards […]
New mechanism of antiviral immunity discovered
Research from the LMB’s PNAC Division has revealed a new mechanism that cells use to fight infection. Jerry Tam and other members of Leo James’s group have discovered that the protein complement C3, which covalently labels viruses and bacteria in the bloodstream, activates a potent immune response upon cell invasion. Molecular biologists chemically modify proteins […]
Melina Schuh and M. Madan Babu awarded Lister Research Prizes
The prestigious Lister Institute Research Prize is awarded annually to three or four young researchers in the UK to support and nurture quality research in biomedical or related biological sciences. This year, two of the recipients are LMB group leaders: Melina Schuh, from the LMB’s Cell Biology Division, and M. Madan Babu, from the LMB’s […]
Protein Synthesis Technology developed at the LMB licenced for use in drug discovery
A method for linking proteins together with specific chemical bonds, developed in the LMB’s PNAC Division by Satpal Virdee and Jason Chin, has been licenced by MRC Technology to the global life sciences company Bio-Techne. The company will use the technology to join ubiquitin, or other proteins, to a target protein, enabling both fundamental research […]